The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Pulmonary embolism - Venous thrombosis/thromboembolism
Publications
Pulmonary embolism due to exogenous estrogen intoxication.
The American journal of emergency medicine 2017 Dec;35;1984.e1-1984.e2 — 2017 Dec — 1984.e1-1984.e2
Thromboembolic events in women exposed to hormonal contraception or cyproterone acetate in 2012: a cross-sectional observational study in 30 French public hospitals.
Drug safety 2014 Apr;37;269-82 — 2014 Apr — 269-82
Combined oral contraceptives: venous thrombosis.
The Cochrane database of systematic reviews 2014 Mar 03;;CD010813 — 2014 Mar 03 — CD010813
Venous thromboembolism in women taking hormonal contraceptives.
Expert review of cardiovascular therapy 2010 Feb;8;211-5 — 2010 Feb — 211-5
Oral contraceptives and the absolute risk of venous thromboembolism in women with single or multiple thrombophilic defects: results from a retrospective family cohort study.
Archives of internal medicine 2007 Feb 12;167;282-9 — 2007 Feb 12 — 282-9
Pulmonary embolism associated with combined oral contraceptives: reporting incidences and potential risk factors for a fatal outcome.
Acta obstetricia et gynecologica Scandinavica 2004 Jun;83;576-85 — 2004 Jun — 576-85
Oral contraceptives and the risk of venous thrombosis.
The New England journal of medicine 2001 May 17;344;1527-35 — 2001 May 17 — 1527-35